Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/9930972 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 02.08.2026. Verfasst von Ting He und 10 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Ningxia.
Abstract (Originalsprache)
Background
Early identification of patients at risk of developing severe coronavirus disease 2019 (COVID‐19) remains a major clinical challenge. Hyaluronic acid (HA), a key component of the extracellular matrix, has been implicated in inflammatory and immune dysregulation. However, its clinical utility as a biomarker for disease severity in hospitalized COVID‐19 patients has not been fully established.
Methods
This prospective observational study included 262 hospitalized patients with confirmed COVID‐19. Serum HA levels measured at admission were analyzed, and patients were stratified into tertiles. Associations between HA levels and disease severity were evaluated using correlation analysis and multivariable logistic regression. Receiver operating characteristic (ROC) curves were constructed to assess the predictive performance of HA alone and in combination with C‐reactive protein (CRP) and D‐dimer.
Results
HA levels were significantly associated with increased disease severity. Patients in the highest HA tertile exhibited a markedly higher proportion of severe and critical illness compared with lower tertiles. In multivariable logistic regression analysis adjusted for age, sex, hypertension, diabetes mellitus, coronary heart disease, and chronic obstructive pulmonary disease, serum HA (OR = 1.002, 95% CI: 1.001–1.004, p = 0.014), CRP (OR = 1.015, 95% CI: 1.006–1.025, p = 0.002), and D‐dimer (OR = 2.464, 95% CI: 1.208–6.913, p = 0.033) were independently associated with severe COVID‐19. ROC analysis showed that HA alone had moderate predictive performance for severe disease (area under the curve [AUC] = 0.648, 95% CI: 0.574–0.721), whereas the combination of HA, CRP, and D‐dimer demonstrated improved discrimination with an AUC of 0.814 (95% CI: 0.757–0.871).
Conclusions
Serum HA measured at hospital admission was independently associated with COVID‐19 severity. The combination of HA with routinely available laboratory markers showed improved discriminative performance in this single‐center cohort, suggesting potential value for risk stratification. However, clinical implementation should be considered preliminary and requires validation in prospective multicenter studies.
Förderung
- Key Research and Development Program of Ningxia
Zitieren
APA
He, T., Du, Y., Ma, J., Yu, W., Li, Y., Wu, T., Zhao, W., Li, J., Zhang, T., Qing, Y., & Zhuan, B. (2026). Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/9930972
Vancouver
He T, Du Y, Ma J, Yu W, Li Y, Wu T, et al. Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/9930972
BibTeX
@article{He2026,
author = {He, Ting and Du, Ying and Ma, Junhui and Yu, Wenqiang and Li, Yinshan and Wu, Tao and Zhao, Wei and Li, Junliang and Zhang, Tuotuo and Qing, Yubo and Zhuan, Bing},
title = {Serum Hyaluronic Acid is Associated With Disease Severity in Hospitalized Patients With COVID‐19: A Prospective Observational Study},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/9930972}
}
EUVIMED